Friday, 20 Apr 2018

You are here

January/February 2016 Top Social Media News

In February 2016, RheumNow published 82 tweets about impactful news, research and teaching points that impact the rheumatology community. These feeds had a reach (impressions) of 80,800 with, 76 mentions, and over 2700 visits to learn on  The average daily “tweet” from RheumNow is seen by 3000-8,000, with as many as 89,500 viewers for a single tweet.  Our social media feeds are just one of several ways we deliver information to over 2500 rheumatologists and 2631 followers on Twitter. The following is a list of top tweets from January and February 2016; news items were selected based on the number of clicks, retweets and likes by the viewership.

  1. CDC issues a Zika Virus update: reviews those at risk and characteristic manifestations: acute fever, maculopapular rash, arthralgia, conjunctivitis, fetal loss, and microcephaly associated with pregnancy.  This was published on 1/25/16 and had a reach of 89,500 viewers.
  2. JAMA Neurology publishes a population study showing that chronic use of proton pump inhibitors is associated with a higher risk of dementia.  Unclear if this association is causal or casual.  Published on 2/15/16 this post was viewed by 28,500.
  3. French guideline published on infection prevention in SLE; overall everyone needs influenza pneumococcal vaccination; avoid live virus vaccines, but no consensus on prophylaxis for pneumocystis.  Published on 2/25/16, this report was viewed by 15,400.
  4. Posterior reversible encephalopathy syndrome (PRES) is a rare CNS manifestation in SLE.  Risk is more common in younger patients and higher in those with hypertension, renal insufficiency, high disease activity, lymphopenia, and interestingly, hyperlipidemia.  This report was posted on 2/29/16 and was seen by 15,400.
  5. A blog on Ten Ways that RA could’ve killed famous Eagle - Glenn Frey.  A major musical loss a reminder how behind we are in our management of RA.   Published on 1/23/16, it was seen by 14,700.
  6. The ocular manifestations of lupus are reviewed in BMJ.  Microangiopathy is the most common finding, but optic neuritis is not common or associated with CNS lupus.  This was published on 1/2/16 and viewed by 14600.  
  7. FDA arthritis advisory committee reviewed a new biosimilar and voted 21-3 in favor of approving Celltrions’ CT-P13 (to be named Inflectra), a biosimilar of infliximab.  This was posted on the day of the meeting, 2/9/16, and was viewed by 14,500.
  8. Nurses health study (>77000) review shows that chronic (4 – 10 yrs.) use of non-aspirin NSAIDs was associated with a significantly higher (34%) increased future risk of renal cell carcinoma.  This was published on 1/14/16 and seen by 13100.  
  9. Cohort review of IBD patients on Infliximab shows that drug induced skin manifestations are not uncommon (23%) and includes eczema and psoriasis like lesions - 41% these were exacerbations of underlying skin conditions.   Published on 2/16/16, the report was seen by 12000.
  10. Metanalyses shows use of the influenza vaccine in lupus is safe; does not induce lupus flares and is moderately effective; although seroconversion rates are lower in lupus patients.  This was posted on 2/24/16 and seen by 8900 viewers.  


The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Medicare Drug Prices Jump Ten Times the Inflation Rate

CNN reports that a new congressional analysis of Medicare drug pricing shows the prices of the 20 most commonly prescribed brand-name drugs have risen nearly 10 times the annual rate of inflation in the past five years.

Shoe Inserts Disappoint with Plantar Heel Pain

A report from the British Journal of Sports Medicine shows that commonly used drug store shoe inserts or customized orthotics are often ineffective in managing plantar heel pain.

Leflunomide May Sensitize the Insulin Receptor and Have an Anti-Glycemic Effect

An animal model study in the Journal of Endocrinololgy reports the potential use of leflunomide in the control of hyperglycemia in male mice. 

2017 Rheumatology Year in Review

This retrospective review is drawn from the authors collection of the most impactful publications, research and news that occurred in 2017.  In no particular order, here are my top rheumatology advances, news and research reports for calendar year 2017.

Oral Anticoagulation Effective Following Hip and Knee Replacement Surgery

Many protocols call for anticoagulation after total hip or total knee arthroplasty to prevent venous thromboembolism (proximal deep-vein thrombosis or pulmonary embolism), and some reports have suggested a role for aspiring or direct oral anticoagulants as preventative therapy. The NEJM has reported that oral anticoagulation with rivaroxaban (Xarelto) followed by aspirin to be effective prophylaxis.